Pain, Multimorbidity, Opioid-Drug Interactions and Risk for Opioid Use Disorder or Overdose in Older Adults
老年人的疼痛、多重发病、阿片类药物相互作用以及阿片类药物使用障碍或过量的风险
基本信息
- 批准号:10659436
- 负责人:
- 金额:$ 40万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-10 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
This study proposes longitudinal research among older adults to assess the associations of uncontrolled pain,
co-occurring chronic conditions or geriatric symptoms (multimorbidity), and opioid–drug interactions with risk
for opioid use disorder (OUD) or overdose (OD). This study is responsive to AHRQ’s special interest (NOT-HS-
21-010) in research to address substance use disorders, including OUD and OD in older adults. Older adults
have experienced significant increases in OUD or OD in the last decade despite a decrease in the number of
opioid prescriptions, signaling an urgent need to identify factors beyond prescription opioid use that contribute
to OUD/OD to inform interventions in older populations. Pain, multimorbidity, and polypharmacy, all strongly
associated with advancing age, are frequently noted as potential risk factors for OUD/OD in older adults, but
relevant evidence is lacking. Relieving pain is the most frequent motive for opioid misuse in older adults, but to
what extent uncontrolled pain contributes to risk for OUD/OD is unknown. Multimorbidity is highly prevalent in
older adults with OUD or OD, but its association with uncontrolled pain and the joint association of
multimorbidity and uncontrolled pain with risk for OUD/OD are unknown. There is also limited understanding
regarding the risk of OUD/OD when prescription opioids for pain treatment are concurrently used with drugs for
other chronic comorbid conditions that may interact with opioids in older adults. To fill these research gaps, this
proposed study will leverage a 100% Medicare sample and Medicare data linked to nationally representative
longitudinal survey data to study the associations of pain, multimorbidity, and opioid-drug interactions with risk
for OUD/OD outcomes of older adults with chronic pain. Specifically, we will examine the associations
between pain control and risk for OUD or OD in older adults diagnosed with chronic pain and treated with
prescription opioids. We will also evaluate the association of multimorbidity with pain control and their joint
association with OUD/OD risk in older patients. Furthermore, we will assess the extent to which concurrent use
of opioids with drugs for treating common comorbid conditions with chronic pain in older adults is associated
with OUD/OD outcomes in older adults with chronic pain. We will measure both pain and high-impact pain and
quantify multimorbidity through both a diagnosis-based index and the presence of geriatric symptoms that are
underdiagnosed or not diagnosable. Our study will provide empirical evidence on the extent to which
uncontrolled pain, multimorbidity, and opioid-drug interactions may play a role in increasing risk for OUD or OD
among older adults with chronic pain. Given the accelerated growth of the US aging population and the
continuing increase in OUD, OD, and opioid misuse, our data will inform interventions that integrate care for
chronic pain and other chronic comorbid conditions to improve pain control while reducing OUD or OD in older
adults.
这项研究建议对老年人进行纵向研究,以评估不受控制的疼痛、
同时发生的慢性病或老年症状(多发病)以及阿片类药物与风险的相互作用
针对阿片类药物使用障碍 (OUD) 或过量 (OD) 这项研究响应了 AHRQ 的特殊兴趣 (NOT-HS-)。
21-010)致力于解决药物滥用障碍的研究,包括老年人的 OUD 和 OD。
尽管在过去十年中 OUD 或 OD 的数量有所减少,但 OUD 或 OD 仍显着增加
阿片类药物处方,表明迫切需要确定处方阿片类药物使用之外的其他因素
OUD/OD 为老年人群的干预措施提供信息,这些都非常重要。
与年龄增长相关,经常被认为是老年人 OUD/OD 的潜在危险因素,但是
缺乏相关证据。缓解疼痛是老年人滥用阿片类药物的最常见动机。
无法控制的疼痛对 OUD/OD 风险的影响程度尚不清楚。
患有 OUD 或 OD 的老年人,但其与不受控制的疼痛以及关节相关
多发病和不受控制的疼痛与 OUD/OD 的风险尚不清楚。
关于用于疼痛治疗的处方阿片类药物与用于治疗疼痛的药物同时使用时 OUD/OD 的风险
可能与老年人中阿片类药物相互作用的其他慢性合并症。
拟议的研究将利用 100% 医疗保险样本和与全国代表性相关的医疗保险数据
研究疼痛、多发病以及阿片类药物相互作用与风险之间关系的纵向调查数据
具体来说,我们将研究患有慢性疼痛的老年人的 OUD/OD 结果。
诊断患有慢性疼痛并接受以下治疗的老年人的疼痛控制与 OUD 或 OD 风险之间的关系
我们还将评估多种疾病与疼痛控制及其关节的关系。
此外,我们将评估同时使用的程度。
阿片类药物与治疗老年人慢性疼痛常见合并症的药物的使用量相关
我们将测量患有慢性疼痛的老年人的 OUD/OD 结果。
通过基于诊断的指数和老年症状的存在来多重量化发病率
我们的研究将为诊断不足或无法诊断的程度提供经验证据。
不受控制的疼痛、多发病和阿片类药物相互作用可能会增加 OUD 或 OD 的风险
鉴于美国人口老龄化的加速增长和慢性疼痛的老年人。
OUD、OD 和阿片类药物滥用的持续增加,我们的数据将为护理干预措施提供信息
慢性疼痛和其他慢性合并症,以改善疼痛控制,同时减少老年人的 OUD 或 OD
成年人。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yu-Jung Wei其他文献
Yu-Jung Wei的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yu-Jung Wei', 18)}}的其他基金
Opioid Prescribing Practices and Health Outcomes among Patients with Alzheimer's Disease and Related Dementia
阿尔茨海默病和相关痴呆症患者的阿片类药物处方实践和健康结果
- 批准号:
10444395 - 财政年份:2022
- 资助金额:
$ 40万 - 项目类别:
Opioid Prescribing Practices and Health Outcomes among Patients with Alzheimer's Disease and Related Dementia
阿尔茨海默病和相关痴呆症患者的阿片类药物处方实践和健康结果
- 批准号:
10693853 - 财政年份:2022
- 资助金额:
$ 40万 - 项目类别:
Prescription Opioid Use Trajectories and Risk Factors Associated with Opioid-Related Hospitalizations in Older Adults
老年人处方阿片类药物使用轨迹和与阿片类药物相关住院相关的风险因素
- 批准号:
10004049 - 财政年份:2019
- 资助金额:
$ 40万 - 项目类别:
Pharmacological Management of Pain In Alzheimer's Disease and Related Dementia
阿尔茨海默病和相关痴呆症疼痛的药理学治疗
- 批准号:
10161046 - 财政年份:2017
- 资助金额:
$ 40万 - 项目类别:
Pharmacological Management of Pain in Alzheimer's Disease and Related Dementia
阿尔茨海默病和相关痴呆症疼痛的药理学治疗
- 批准号:
9535032 - 财政年份:2017
- 资助金额:
$ 40万 - 项目类别:
Pharmacological Management of Pain in Alzheimer's Disease and Related Dementia
阿尔茨海默病和相关痴呆症疼痛的药理学治疗
- 批准号:
9386225 - 财政年份:2017
- 资助金额:
$ 40万 - 项目类别:
Pharmacological Management of Pain in Alzheimer's Disease and Related Dementia
阿尔茨海默病和相关痴呆症疼痛的药理学治疗
- 批准号:
10187473 - 财政年份:2017
- 资助金额:
$ 40万 - 项目类别:
相似海外基金
A benefit-risk trial of 1-month rifapentine and isoniazid to prevent tuberculosis and reduce morbidity in people with non-communicable multimorbidity
一项为期 1 个月的利福喷汀和异烟肼预防结核病并降低非传染性多病患者发病率的效益风险试验
- 批准号:
MR/Y004914/1 - 财政年份:2024
- 资助金额:
$ 40万 - 项目类别:
Research Grant
An AI-enabled multimorbidity care service
基于人工智能的多病种护理服务
- 批准号:
10099910 - 财政年份:2024
- 资助金额:
$ 40万 - 项目类别:
Collaborative R&D
An Integrated Life-Course Approach for Person-Centred Solutions and Care for Ageing with Multimorbidity in the European Regions - STAGE; Stay Healthy Through Ageing (STAGE)
欧洲地区以人为本的解决方案和多病态老龄化护理的综合生命全程方法 - STAGE;
- 批准号:
10109957 - 财政年份:2024
- 资助金额:
$ 40万 - 项目类别:
EU-Funded
ARISTOTELES - Applying ARtificial Intelligence to Define clinical trajectorieS for personalized predicTiOn and early deTEctiOn of comorbidiTy and muLtimorbidiTy pattErnS
亚里士多德 - 应用人工智能定义临床轨迹,以实现个性化预测以及合并症和多发病模式的早期检测
- 批准号:
10103153 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
EU-Funded
Multimorbidity in Children and Youth Across the Life-course (MY LIFE): A Long-term Follow-up
儿童和青少年一生中的多重疾病(我的一生):长期随访
- 批准号:
483695 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Operating Grants